Madrigal Pharmaceuticals

Home » Madrigal Pharmaceuticals

Secondary

Madrigal Pharmaceuticals

They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases.

Symbol

MDGL

Last Closing Price
$82.47

Shares
1,200,000

Effective Date
December 19, 2017

Underwriters
Goldman Sachs

To view the prospectus for Madrigal Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253